-
Mashup Score: 31CZI Neurodegeneration Challenge Network Projects - 2 month(s) ago
We’re proud to support research that aims to advance the study of neurodegenerative disease and accelerate progress toward cures.
Source: chanzuckerberg.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 7How Fast Can We Solve Alzheimer’s? - 3 month(s) ago
How Fast Can We Solve Alzheimer’s? – Wednesday, January 31, 2024
Categories: General Medicine News, PayerTweet
-
Mashup Score: 3First Cases of Medically Acquired Alzheimer's Disease Reported - 3 month(s) ago
Patients who received contaminated growth hormone developed AD decades later. The study suggests AD is transmissible, but researchers stress it cannot be transmitted through routine medical care.
Source: www.medscape.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 3First Cases of Medically Acquired Alzheimer's Disease Reported - 3 month(s) ago
Patients who received contaminated growth hormone developed AD decades later. The study suggests AD is transmissible, but researchers stress it cannot be transmitted through routine medical care.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Login to your account - 4 month(s) ago
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? Alexander Scott, Executive Vice President, Integrity, Eisai Inc. | December 17, 2023 Publisher’s note: This post is paid for and provided by Eisai Inc. The views expressed by the author are their own. Bringing new therapeutic modalities to patients takes a significant amount of time, expertise and investment; however,
Source: www.healthaffairs.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Login to your account - 4 month(s) ago
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? Alexander Scott, Executive Vice President, Integrity, Eisai Inc. | December 17, 2023 Publisher’s note: This post is paid for and provided by Eisai Inc. The views expressed by the author are their own. Bringing new therapeutic modalities to patients takes a significant amount of time, expertise and investment; however,
Source: www.healthaffairs.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
“It’s important that we inform our patients that really, even with this therapy, there’s no prospect of stabilizing or restoring cognition or function,” said Dr. Meredith Wicklund, MD.
Source: www.mdedge.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Untangling Tau | Biogen - 5 month(s) ago
The expression of tau in the brain is linked to the symptomatology of Alzheimer’s, and while the precise toxic form of the protein is not yet understood, Dominic Walsh, Ph.D., head of Biogen’s Neurodegenerative Diseases Unit, believes that it is still possible to develop effective therapies for the disease.
Source: www.biogen.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 2First-in-Class Regenerative Therapeutic for AD Promising - 6 month(s) ago
Allopregnanolone has the potential to delay neurodegeneration in early Alzheimer’s disease by promoting endogenous systems of renewal and repair, early testing shows.
Source: www.medscape.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 8No Influence of APOE Status on Donanemab Efficacy - 6 month(s) ago
New data from TRAILBLAZER-ALZ 2 show robust amyloid clearance with donanemab in APOE4 carriers and noncarriers, mitigating the risk of disease progression and dependency.
Source: www.medscape.comCategories: General Medicine News, General NewsTweet
A HUGE✨CONGRATULATIONS✨to Drs @JM_Castell & @wuzhengherbert on receiving a @ChanZuckerberg Collaborative Pairs Pilot Project Award for their work on "Molecularly-Defined Neural Cells Altered by #AlzheimersDisease Pathology"👏Learn More: https://t.co/HYAMPITWIb https://t.co/qc0Gd4i6vn